Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.82 HKD | 0.00% | -1.20% | -10.87% |
Apr. 30 | LH Group Limited Announces Board and Committee Changes | CI |
Apr. 29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
Sales 2022 | 1.07B 137M | Sales 2023 | 1.28B 164M | Capitalization | 736M 94.37M |
---|---|---|---|---|---|
Net income 2022 | 77M 9.87M | Net income 2023 | 88M 11.28M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 118M 15.16M | Net Debt 2023 | 2.46M 316K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
8.36
x | Employees | 1,291 |
Yield 2022 |
7.26% | Yield 2023 |
9.58% | Free-Float | 25% |
1 week | -1.20% | ||
Current month | -1.20% | ||
3 months | -10.87% | ||
6 months | -18.00% | ||
Current year | -10.87% |
Managers | Title | Age | Since |
---|---|---|---|
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Dong John Yang
DFI | Director of Finance/CFO | 49 | 23-04-10 |
Hiu Yi Chan
ADM | Chief Administrative Officer | 38 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wai Man Hung
BRD | Director/Board Member | 55 | 18-05-29 |
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Sau Chee Ko
BRD | Director/Board Member | 58 | 17-06-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 0.82 | 0.00% | 642 000 |
24-05-17 | 0.82 | 0.00% | 1,058,000 |
24-05-16 | 0.82 | -1.20% | 1,290,000 |
24-05-14 | 0.83 | 0.00% | 916,000 |
24-05-13 | 0.83 | 0.00% | 456,000 |
Delayed Quote Hong Kong S.E., May 20, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.87% | 84.09M | |
+38.79% | 11.33B | |
+18.54% | 8.76B | |
+44.88% | 2.78B | |
+4.25% | 2.26B | |
-12.31% | 2.09B | |
+9.80% | 1.96B | |
-0.37% | 1.47B | |
-15.90% | 918M | |
+1.94% | 858M |
- Stock Market
- Equities
- 1978 Stock